对于痴呆症患者的在线同行支持:一个范围审查协议
Esther Vera Loseto-Gerritzen1, Catherine Talbot2, Orii McDermott1
1Institute of Mental Health, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
JBI evidence synthesis
|March 19, 2025
概括
本范围审查探讨了对痴呆症患者的在线同行支持,综合了可用的平台和沟通方法. 它强调了数字支持对痴呆症患者的好处,解决了当前研究中的差距.
科学领域:
- 老年学是指老年学的学科.
- 数字健康数字健康
- 神经科学是一个神经科学.
背景情况:
- 痴呆症患者利用各种在线平台,包括社交媒体和视频会议,以获得同行支持.
- 在线同行支持提供了诸如克服地理限制和个性化沟通选择等好处.
- 目前缺乏对痴呆症现有的在线同行支持机会的全面综合.
研究的目的:
- 对被诊断患有痴呆症的个人进行在线同行支持机会的范围审查.
- 确定和综合用于痴呆症同行支持的数字平台和方法的范围.
- 为痴呆症社区提供关于在线同行支持的洞察力.
主要方法:
- 该审查遵循乔安娜·布里格斯研究所 (JBI) 的范围审查方法.
- 在多个数据库,搜索引擎和组织网站上采用了全面的搜索策略.
- 数据提取和研究选择由两名独立审查员进行,第三名审查员为达成共识.
主要成果:
- 审查确定了各种在线平台,用于痴呆症患者的同行支持.
- 提取了在线同行支持平台及其利用的关键特征.
- 结果将通过表格和叙事总结来详细介绍可用的机会.
结论:
- 本综述综合了目前在线同行支持痴呆症患者的现状.
- 这些发现将为痴呆症社区的数字支持网络的开发和可访问性提供信息.
- 了解这些平台可以提高痴呆症患者的生活质量和社会联系.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Peripheral Artery Disease III: Interprofessional Care
659
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
Dementia
693
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
693
Alzheimer Disease l: Introduction
29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


